G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial

GA trial is registered under EudraCT#: 2013-001639-38.

Detalles Bibliográficos
Autores principales: Stopka, Tomáš, Minařík, Lubomír, Dusilková, Nina, Pešta, Michal, Kulvait, Vojtěch, Špaček, Martin, Zemanová, Zuzana, Kalousová, Marta, Jonášová, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262924/
https://www.ncbi.nlm.nih.gov/pubmed/35798720
http://dx.doi.org/10.1038/s41408-022-00698-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262924/
https://www.ncbi.nlm.nih.gov/pubmed/35798720
http://dx.doi.org/10.1038/s41408-022-00698-2

Ejemplares similares